- Home
- IMNN vs FLGC Comparison
IMNN vs FLGC Comparison
Compare IMNN & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- FLGC
- Stock Information
- Founded
- IMNN 1982
- FLGC 2019
- Country
- IMNN United States
- FLGC United States
- Employees
- IMNN N/A
- FLGC N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- IMNN Health Care
- FLGC Health Care
- Exchange
- IMNN Nasdaq
- FLGC Nasdaq
- Market Cap
- IMNN 12.9M
- FLGC 13.5M
- IPO Year
- IMNN 1985
- FLGC 2021
- Fundamental
- Price
- IMNN $3.77
- FLGC $7.55
- Analyst Decision
- IMNN Buy
- FLGC Strong Buy
- Analyst Count
- IMNN 2
- FLGC 1
- Target Price
- IMNN $182.61
- FLGC $156.00
- AVG Volume (30 Days)
- IMNN 56.4K
- FLGC 14.8K
- Earning Date
- IMNN 11-13-2025
- FLGC 11-05-2025
- Dividend Yield
- IMNN N/A
- FLGC N/A
- EPS Growth
- IMNN N/A
- FLGC N/A
- EPS
- IMNN N/A
- FLGC N/A
- Revenue
- IMNN N/A
- FLGC $57,609,000.00
- Revenue This Year
- IMNN N/A
- FLGC N/A
- Revenue Next Year
- IMNN N/A
- FLGC $10.48
- P/E Ratio
- IMNN N/A
- FLGC N/A
- Revenue Growth
- IMNN N/A
- FLGC 24.71
- 52 Week Low
- IMNN $3.56
- FLGC $6.80
- 52 Week High
- IMNN $41.22
- FLGC $81.90
- Technical
- Relative Strength Index (RSI)
- IMNN 35.44
- FLGC 36.98
- Support Level
- IMNN $3.56
- FLGC $6.80
- Resistance Level
- IMNN $4.38
- FLGC $8.00
- Average True Range (ATR)
- IMNN 0.30
- FLGC 0.89
- MACD
- IMNN 0.00
- FLGC 0.31
- Stochastic Oscillator
- IMNN 21.95
- FLGC 40.00
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.